Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

17. Oktober 2016 08:30 ET | Quelle: Integra LifeSciences Holdings Corporation

Integra LifeSciences Organizes Hands-on Wound Workshop on Best Practices for Omnigraft® Dermal Regeneration Matrix and PriMatrix® Dermal Repair Scaffold at Symposium on Advanced Wound Care (SAWC) Fall Meeting

PLAINSBORO, N.J., Oct. 17, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) recently organized a hands-on regenerative wound management workshop at the Symposium on...
01. August 2016 08:30 ET | Quelle: Integra LifeSciences Holdings Corporation

Integra LifeSciences Announces that Omnigraft™ Dermal Regeneration Matrix was Recognized as a Top Ten Innovation by Podiatry Today

PLAINSBORO, N.J., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that its recently introduced...
11. Mai 2016 08:30 ET | Quelle: Integra LifeSciences Holdings Corporation

Integra LifeSciences Receives FDA Approval for Integra® Omnigraft™ Dermal Regeneration Matrix, Clearing the Way for Commercial Release

PLAINSBORO, N.J., May 11, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the Company has...
27. April 2016 06:00 ET | Quelle: Integra LifeSciences Holdings Corporation

Integra LifeSciences Provides Update for Omnigraft™ Commercialization Plans, Including Expectations for an Earlier Launch

PLAINSBORO, N.J., April 27, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the Company is...